Ascentage Pharma Group International (AAPG)vsRevolution Medicines Inc (RVMD)
AAPG
Ascentage Pharma Group International
$15.58
-1.83%
HEALTHCARE · Cap: $1.41B
RVMD
Revolution Medicines Inc
$190.74
-1.10%
HEALTHCARE · Cap: $41.32B
Smart Verdict
WallStSmart Research — data-driven comparison
Ascentage Pharma Group International generates 86508% more annual revenue ($642.63M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -228.5%. AAPG earns a higher WallStSmart Score of 25/100 (F).
AAPG
Avoid25
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 29.3% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Trading at 17.5x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Trading at 15.7x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : AAPG
The strongest argument for AAPG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : AAPG
The primary concerns for AAPG are Price/Book, EPS Growth, Market Cap. Debt-to-equity of 3.76 is elevated, increasing financial risk.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
AAPG profiles as a growth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
AAPG is growing revenue faster at 29.3% — sustainability is the question.
AAPG generates stronger free cash flow (-612M), providing more financial flexibility.
Bottom Line
AAPG scores higher overall (25/100 vs 24/100) and 29.3% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ascentage Pharma Group International
HEALTHCARE · BIOTECHNOLOGY · USA
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company is headquartered in Suzhou, China.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?